Nordex

Phase A — Understand the business

Lens 1 · Company Overview

Nordex SE designs, manufactures, installs and services onshore wind turbines. It is a pure-play onshore OEM — it exited offshore in 2018 (sold the offshore unit to Siemens years earlier) and does not compete in the deep-water business that dominates Vestas/Siemens Gamesa/GE headlines. The business has two segments:

1. Projects (turbines): ~90% of revenue. Sell-and-install multi-MW turbines, principally the Delta4000 geared platform (4–7 MW class), with the newest addition the N175/6.X — a single-piece 85.7m blade delivering a claimed 7–14% yield uplift at low/medium-wind sites vs predecessor models. Revenue is milestone/percentage-of-completion on turbine supply + installation.
2. Service: ~11% of revenue but structurally the crown jewel — recurring, high-margin O&M contracts. At Q1 2026 the service book covered 13,929 turbines / 49.4 GW under contract, average tenor >13 years, service order book €6.5bn, and a ~19% service EBIT margin. This is the annuity that de-risks the cyclical projects segment.

Scale (FY2025): revenue €7,553.5m, EBITDA €631.0m (8.4% margin), net income €274.3m, produced 1,437 turbines / 8,540 MW (+12.2% output). Record order intake €9.3bn / 10.2 GW (+22.5% GW YoY).

Customers: utility-scale developers and utilities buying under long-term PPAs/auction awards — RWE, Acciona Energía, EDP, Statkraft, Iberdrola-type buyers and a long tail of European IPPs (specific FY2025 named split not disclosed publicly; customers.csv empty). Core markets: Germany, USA, Turkey, Brazil.

Ownership is the atypical feature. Spanish infrastructure group Acciona is the controlling anchor shareholder (reported variously 33.7%–41% economic / up to ~47% voting rights by early 2025 — sources conflict, flagged in Lens 9), with RWE holding ~10.8% (acquired late 2024) and the Klatten family (SKion/Momentum) a legacy holder. Acciona is both parent-like backstop and a customer — a governance double-edge (Lens 9/13).

Lens 2 · Supply Chain

Upstream inputs → Nordex → end customer, named where sourceable:

• In-house manufacturing (vertical where it matters): Nordex produces its own nacelles, rotor blades and concrete towers. Nacelle assembly and blade/tower plants span Germany (Rostock — nacelles/blades), Spain, Brazil, USA, Mexico (new blade plant), India, Poland. Concrete-tower know-how is a genuine asset: 15+ years, ~2,600 units across 10 countries — towers are heavy/low-value-density, so local concrete production is a logistics moat in LatAm/emerging markets.
• Bought-in drivetrain components (the chokepoints): gearboxes, generators, converters are integrated by a "Global Nacelle Team" spanning Germany, Spain, India, Brazil, USA and China. Gearboxes are the classic wind chokepoint — a handful of suppliers globally (ZF/Winergy, Flender). Large castings and main bearings (China/Europe concentrated) and balsa/carbon for blades are the other pinch points. Exact tier-1 supplier names for FY2025 not disclosed publicly — `` general-industry structure, not company-confirmed.
• Rare-earth angle (a relative advantage): Nordex's Delta4000 uses a geared (medium-speed) drivetrain, not large permanent-magnet direct-drive. That means materially less heavy-rare-earth (NdFeB magnet) dependency than direct-drive rivals (Goldwind, some Siemens Gamesa) — a resilience edge as China tightens rare-earth export controls. Caveat: gearboxes themselves reintroduce a supply chokepoint.
• Steel/raw materials: towers and components are steel/concrete-intensive; 2021–22 showed the P&L is highly sensitive to steel, resin, logistics and energy cost spikes (that shock nearly broke the company — Lens 8).

Verdict on the chain: globally distributed, partly vertically integrated on the heavy/local items (towers, blades), exposed on drivetrain components — but less rare-earth-exposed than direct-drive peers. Names present where public; deeper tier-1 mapping is the gap a filing-grounded refresh can't close (no EDGAR).

Lens 3 · Competitive Advantages (moats)

1. Installed-base service annuity (the real moat). 49.4 GW / ~14,000 turbines under >13-year contracts at ~19% EBIT margin is a recurring, switching-cost-protected cash stream that compounds with every turbine sold. This is the highest-quality part of the business and the structural argument for a re-rating.
2. European onshore leadership + policy moat. Nordex is a top-tier European onshore supplier (cited as European order-intake leader by at least one source) and — critically — a named beneficiary of the EU Net-Zero Industry Act non-price criteria. From 30 Dec 2025, member states must apply sustainability/resilience/cybersecurity criteria (15–30% award weight) to ≥30% of auctioned capacity or ≥6 GW/yr, and favour non-China sourcing where one non-EU country supplies >50% of demand. Sustainalytics explicitly names Vestas and Nordex as beneficiaries. This is a regulatory tilt of the playing field against Chinese price competition in Nordex's core market.
3. Delta4000 platform maturity + LatAm concrete-tower footprint. Series-production technology plus local concrete-tower manufacturing in Brazil/Mexico/etc. is a hard-to-replicate logistics advantage in emerging onshore markets.
4. Bargaining power — mixed. Over customers: moderate (utility buyers are large and price-sensitive; onshore turbines are semi-commoditised on the metal, differentiated on yield/AEP and service). Over suppliers: weak-to-moderate on drivetrain chokepoints. The moat is service + policy + platform, not pricing power on the turbine itself.

Durability caveat: onshore turbine hardware is the least moated part of wind — this is why the whole industry's OEM margins are thin and cyclical. Nordex's moat is real but concentrated in the service book and the current EU policy window.

Lens 4 · Segments

segments.csv is empty — all figures , not .

By segment (FY2025 / latest):

Note: one source line matched FY2025 "service revenue €863.3m" to the identical FCF figure — likely a WebFetch mismatch; the defensible read is service revenue ~€0.8bn annualised from the €217.9m Q1'26 print. Flagged, not asserted.

By geography (turbine order book, end-2025): Europe ~89%, Latin America ~8%, North America ~2%, RoW ~1%. Europe-concentration is the structural fact — a strength (policy tailwind, market leadership) and a risk (single-region demand dependency). The 2026 shift to watch: the US went from a rounding error to ~809 MW of order intake in Q2 2026 alone — the beginning of geographic diversification and the clearest new growth vector.

Why the trend matters: rising ASP (€0.87→€0.97m/MW, +11% in five quarters) is higher-priced backlog converting into revenue — the mechanical driver of the margin ramp from 5.5% (Q1'25) to 8.2% (Q1'26). This is the single most important trend in the whole dossier.

---

Phase B — Measure performance

Lens 5 · Earnings Result (Q1 2026, latest print + FY2025 anchor)

Q1 2026 (reported 2026-04):

• Sales €1,587.7m (+10.6% YoY); EBITDA €130.7m; EBITDA margin 8.2% (up from 5.5% Q1'25) — the headline: +270bps margin expansion YoY.
• Net income €53.6m (vs a near-breakeven prior-year Q1).
• Installations 1,155 MW / 227 turbines / 14 countries; production capacity 1,494 MW (+23.5%).
• Net cash €1,518.4m; cash €1,829.1m. FCF −€98.1m (normal Q1 seasonal working-capital outflow; WC ratio −9.0% vs −12.4% at YE, still comfortably negative = customer-financed).
• Total order book €17.0bn (Projects €10.5bn +27% YoY; Service €6.5bn +24% YoY) — all-time high.
• Order intake 1.9 GW (1,869 MW), down 14.3% YoY — the one blemish, but lumpy quarter-timing, not trend (Q2 2026 order intake then jumped +32% to 3.1 GW).

FY2025 anchor: revenue €7,553.5m; EBITDA €631.0m (8.4%); net income €274.3m; FCF €863.3m (record); net cash €1,624.7m; capex €168.9m; WC ratio −12.4%. Beat its own 8% mid-term margin target a year early and raised the mid-term target to 10–12%.

Guidance FY2026: sales €8.2–9.0bn, EBITDA margin 8–11%, capex ~€200m, WC ratio below −9%.

Market reaction: the stock is +119.7% over 52 weeks — the market has priced the turnaround. Q2 2026 order beat (+32%) pushed shares ~4% higher on the day. The tape says: earnings/margin beats and order intake are both being rewarded; the risk is the bar is now high.

Anything unusual vs its own history: yes — everything. Net cash (was net debt + liquidity-stressed in 2022), record FCF, double-digit mid-term margin target. This is a different company than 24 months ago.

Lens 6 · Earnings Calls (sentiment trend)

No transcripts on the shelf — sentiment read from the sequence of IR releases + commentary, ``.

The tonal arc across the last ~5 quarters is one of the cleanest "management confidence inflections" in European industrials:

• 2024 → early 2025: "stabilisation," "return to profitable growth," "positive free cash flow" — cautious, proving-it language.
• Q3 2025: raised full-year EBITDA-margin guidance on strong preliminary figures — tone shifts to confident.
• Q4/FY2025: "exceeded mid-term target," raised the mid-term target to 10–12% — management is now leaning forward, not defending.
• Q1/Q2 2026: "continued margin improvement," "strengthening position in core markets," US milestone framed as validation ("the trust customers place in us").

Recurring phrases: profitable growth, operational excellence, margin improvement, positive free cash flow, disciplined project selection. Things they've stopped saying: warranty/quality provisions, liquidity, refinancing, "challenging environment," turnaround. The disappearance of the crisis vocabulary is itself the signal. Risk: confidence + raised targets = raised expectations; a single soft print now carries more downside than it did in the humble-2024 posture.

Lens 7 · Comps

Peer set: Western onshore/wind-exposed OEMs. Multiples ``, dated; n/a where I could not source a clean figure. No fabricated multiples.

Read: on forward P/E, Nordex (17.9x) screens cheaper than Vestas (~25x) and on EV/EBITDA (11.7x) cheaper than most of the set — despite the 120% run. That is the crux of the reasonable-not-cheap verdict: the trailing 32.8x looks scary, but forward multiples embed the margin ramp and are undemanding if the 10–12% mid-term margin lands. Nordex is the only name in the set with a net-cash balance sheet and a clean onshore-only story (no offshore project-loss tail risk that has plagued Siemens Gamesa and GE). Multiples conflict across sources — treat the table as directional, not precise.

Lens 8 · Stock-Price Catalysts (5-yr pattern)

The chart is a near-death-and-resurrection, and it tells you exactly what moves this name:

• 2021–2022 collapse: supply-chain/inflation shock + a Conti ransomware attack (31 Mar 2022) + serial warranty/quality costs drove FY2022 loss ~€522m, current liabilities +47% to €3.4bn. Stock fell to low-single/high-single-digit euros.
• 2021–2023 dilutive capital raises: multiple rights issues (2021 42.7m shares; July 2022 €212m at €5.90/share), convertible bonds, Acciona backstopping — survival financing that consolidated Acciona's control. Share count is still rising (+11.75% YoY) — dilution is a live theme.
• 2024 stabilisation → 2025–2026 re-rating: return to profit, record FCF, net-cash flip, raised mid-term margin target → +119.7% over the last 52 weeks, 200-DMA €35.8 vs 50-DMA €43.8.

What the market actually reacts to for NDX1: (1) margin/EBITDA guidance changes (every raise = re-rate leg), (2) quarterly order intake (the +32% Q2'26 beat popped it ~4%), (3) ASP trend (the pricing-power proxy), and (4) balance-sheet/liquidity news (the 2022 rights issues crushed it). It is not a name that trades on a single customer. From here, the swing factors are the mid-term margin proof and any China-in-Europe pricing headline.

---

Phase C — Judge people & books

Lens 9 · Management

• CEO José Luis Blanco — CEO since March 2017, contracted through Dec 2028. Ex-Acciona Windpower MB (2012), 15 years at Gamesa (incl. Gamesa USA COO/MD). Track record: the architect of both the 2016 Acciona-Windpower integration and the 2021–2023 survival-and-turnaround. Double-edged — he was also CEO through the near-death crisis — but the scoreboard now (net cash, record FCF, 8.4%→10–12% margin path) is a genuine operator win. Total comp ~$2.11m (about average for the size; +20% last year). Not a promotional/overpaid profile.
• CFO Christoph Burkhard; CSO Patxi Landa — stable senior bench; Landa (sales) is another Acciona/Gamesa-lineage operator.
• Skin in the game / insider ownership: low direct management ownership (typical for a European corporate); the real ownership story is Acciona's control — which cuts both ways. Aligned on value creation, but a controlling shareholder that is also a customer and a former parent creates related-party and minority-protection questions (Lens 13). insider-transactions.csv absent.
• Capital allocation: the last three years were forced allocation — dilutive raises to survive, then deleveraging. No dividend, no buyback (appropriate — reinvest/rebuild balance sheet first). The next capital-allocation decision is the real test: with €1.6bn net cash and €863m FCF, does management return cash, reinvest in US/capacity, or does Acciona steer it? ROE has swung from deeply negative (2022) to positive; ROIC trend improving but not yet proven through-cycle.
• Archetype: professional manager (industry lifer), not founder. Right archetype for a scale-execution phase.

Governance flag: the Acciona overhang (control without full ownership, board seats, customer relationship) is the single biggest governance item — not disqualifying, but it caps the "clean minority shareholder" quality and is why a takeover-to-full-control or a related-party pricing question is always latent.

Lens 10 · Forensic Red Flags + Regulatory

Web-only forensic read — no filings on the shelf to reconcile cash-vs-earnings line by line. Flag the classes of risk, don't fabricate reconciliations.

• Warranty / serial-defect provisions — the classic wind-OEM accounting risk and the actual driver of the 2021–22 losses. Onshore OEMs capitalise/accrue warranty on multi-year turbine guarantees; under-accrual flatters current margin and bites later. With margins now ramping fast, the question is whether provisioning is keeping pace with volume — the #1 forensic item to verify in the annual report (Item on provisions in the Integrated Annual Report 2025, not on shelf).
• Percentage-of-completion revenue recognition — turbine/installation revenue is milestone-based; POC gives management estimation latitude on timing. Watch contract-asset/liability and the strongly negative working-capital ratio (−12.4%): it's a strength (customer prepayments fund the business) but it also means reported FCF is flattered by advance payments — a demand slowdown reverses the WC tailwind fast (Q1'26 already showed −€98m FCF as WC normalised). Record FY25 FCF €863m is partly a WC-timing gift, not all structural.
• Dilution / SBC — share count +11.75% YoY; recurring capital raises mean per-share metrics lag headline growth. Not fraud, but a persistent per-share drag.
• Non-recurring add-backs — "EBITDA margin" is the headline metric; below it, D&A and warranty true-ups make EBIT margin materially thinner. Judge on EBIT/net income, not just EBITDA.

Regulatory findings (required):

• SEC (EDGAR EFTS — LR + AAER): No CIK; Nordex is not an SEC filer, so no EDGAR enforcement search is possible. Zero SEC findings by construction, not by exoneration.
• Non-SEC enforcement (web): no material FTC/DOJ/EU antitrust/consumer-protection actions surfaced against Nordex. The one notable adversarial event is the Conti ransomware attack (31 Mar 2022) — a victim incident, contained to internal IT with turbines unaffected and no confirmed material data release. This is a resolved operational-security event, not a regulatory sanction.
• Item 3 / Legal Proceedings equivalent: no 10-K on shelf (foreign filer). No material litigation surfaced via web as of 2026-07-10.
• Conclusion: No material regulatory or legal findings — verified via SEC EDGAR EFTS (no CIK, LR + AAER n/a), web enforcement search, and public disclosure review as of 2026-07-10. The genuine forensic risk here is warranty adequacy + WC-flattered FCF, not enforcement.

---

Phase D — Project & stress-test

Lens 11 · Forward Projection

All with arithmetic; consensus anchors. No forecast.ts create (watchlist/unattended rule).

Anchors: FY2025 actual EPS ≈ €1.16–1.24 (net income €274.3m ÷ ~236.5m shares). Consensus FY2026E EPS ~€1.84–1.89 (raised from €1.34). FY2026 guidance: sales €8.2–9.0bn, EBITDA margin 8–11%. No clean 2027/2028 consensus sourced.

Bottom-up, three years forward:

• Bull: mid-term 12% margin lands by 2027, US scales, service compounds → 2028E EPS ~€3.40.
• Bear: European auction air-pocket + Chinese onshore price entry compress ASP and margin back toward 7–8%; a demand slowdown reverses the WC/FCF tailwind → 2028E EPS ~€1.70.

The projection call: the base case has EPS roughly 2.5x'ing from €1.16 (2025) to ~€2.90 (2028E) on margin ramp + modest growth. At €40.76 that is ~14x 2028E base EPS — not demanding if the margin path holds. The entire thesis reduces to does the 10–12% mid-term EBITDA margin actually land, and does negative working capital hold?

(Brier forecast to log if promoted: "NDX1 FY2027 EBITDA margin ≥ 10.0%", p≈0.62, resolves 2028-02-28 — not created here per watchlist rule.)

Lens 12 · Bull vs Bear

Bull case. Nordex is a structurally different, de-risked company that the multiple hasn't fully caught up to on a forward basis. Record €17bn backlog gives multi-year revenue visibility; the service annuity (49.4 GW, ~19% EBIT margin, >13yr tenor) is a compounding, switching-cost-protected cash engine; ASP is rising (€0.87→€0.97m/MW) = real pricing power as the industry consolidates and supply tightens; net cash €1.6bn + €863m FCF removes the balance-sheet tail risk that defined the stock for three years; and — the underappreciated kicker — EU Net-Zero Industry Act non-price criteria explicitly tilt European auctions toward EU OEMs like Nordex against subsidised Chinese entrants, plus a genuine new US growth leg (809 MW in Q2'26 alone). Management raised the mid-term margin target; forward P/E ~18x / EV-EBITDA ~12x is reasonable for a high-single-digit grower with margins going to double digits.

Bear case. Three things that could permanently impair it: (1) onshore turbine hardware is the least-moated slice of wind — through-cycle OEM margins have historically been thin and violently cyclical; the current 8–11% could prove a peak, not a floor. (2) Chinese OEMs are coming to Europe (Mingyang-Octopus 6 GW UK, SANY German/Spanish plants from 2026, ~20% price discount) — even if onshore penetration lags offshore, the price umbrella Nordex is enjoying can compress. (3) Demand is policy- and rate-dependent and Europe-concentrated (89%) — an auction slowdown, permitting drag, or rate-driven PPA economics reverse both revenue and the negative-working-capital FCF tailwind at once. Pre-mortem (18 months out, thesis broken): the mid-term margin stalls at ~8%, a European auction air-pocket hits order intake, the WC tailwind unwinds, FCF halves, and a 32x-trailing / 18x-forward multiple compresses to 10–11x — the stock round-trips a chunk of the 120% run. Contrarian view the market may be missing: the service book, not the turbine cycle, is the durable value — and it's underpriced inside a name still tape-traded as a cyclical turnaround.

Lens 13 · Devil's Advocate (short-seller)

Dismantling the bull case:

• The re-rating already happened. +120% in a year; consensus 12-month targets cluster €41–46 vs €40.76 spot (only ~2–12% upside; wide dispersion, low €15.8). You are buying after the sell side already marked it up — the easy money in the recovery is gone.
• Margin is the whole thesis and it's cyclical + provision-dependent. If warranty provisioning is under-accruing into a volume ramp (the exact 2021–22 failure mode), today's 8–11% margin is borrowed from tomorrow's true-ups. There is no filing on the shelf to check this — that opacity is the risk.
• FCF is flattered by negative working capital. €863m record FCF leans on customer prepayments (−12.4% WC ratio). That is a demand-strength metric masquerading as a quality metric — Q1'26 already flipped to −€98m FCF as WC normalised. A soft order year unwinds it hard.
• Acciona overhang. A controlling shareholder that is also a customer and ex-parent — related-party pricing, board control, and the permanent latent question of a squeeze-out at a chosen (low) moment. Minority holders ride shotgun.
• Dilution is structural, not one-off — +11.75% shares YoY; per-share compounding lags the headline.
• Most dangerous competitor bulls underestimate: not Vestas — the Chinese onshore OEMs (Goldwind/Envision/Mingyang), who took the entire global top-6 in 2025 and are methodically probing Europe with a ~20% price advantage and state backing. The NZIA is a levee, not a wall.
• If growth disappoints 20–30%: revenue to ~€6.5–7bn, margin to 7–8%, EPS to ~€1.30, WC/FCF reversal — a 10–11x multiple puts the stock closer to €25–30, i.e. meaningful downside from €40.

The one scenario that permanently impairs it: a synchronised European auction slowdown plus Chinese onshore price entry that structurally caps ASP — turning the "rising ASP / double-digit margin" story back into the "thin cyclical OEM" it was for a decade. Plausibility: moderate, not remote.

Lens 14 · Management Questions (ordered by information value)

1. Warranty & serial-defect provisioning: how has the provision-to-revenue ratio moved as volume/ASP rose, and what gives you confidence current accrual rates won't require the kind of true-ups that drove the 2021–22 losses?
2. Mid-term 10–12% EBITDA margin: what specifically bridges 8.4% (2025) to 12% — how much is higher-priced backlog conversion (a one-time ASP step) vs. structural cost-out that survives a down-cycle?
3. Working capital: the −12.4% WC ratio flatters FCF via prepayments — at what order-intake growth rate does WC turn from tailwind to headwind, and what is normalised through-cycle FCF conversion?
4. China in Europe: as Mingyang/SANY/Goldwind localise European manufacturing, where do you concede share vs. defend on price, and how much ASP cushion does the NZIA non-price criteria actually buy you in real auctions?
5. Capital allocation: with €1.6bn net cash and €863m FCF, what is the framework — dividend, buyback, US/capacity capex — and how does Acciona's board influence it?
6. US strategy: the 809 MW Q2'26 order is a milestone — is this a durable second leg, or opportunistic given US policy/IRA volatility, and what US manufacturing footprint would you commit?
7. Acciona related-party governance: what arm's-length safeguards govern Acciona-as-customer pricing, and what protects minority holders against a future control transaction?
8. Service margin durability: is ~19% service EBIT margin sustainable as the fleet ages, and what is the attach/renewal rate on the 49.4 GW under contract?
9. ASP trajectory: €0.87→€0.97m/MW in five quarters — how much is mix/scope vs. genuine pricing power, and where does ASP normalise?
10. Drivetrain supply chain: how exposed are you to gearbox/bearing/casting chokepoints, and how does the geared architecture's lower rare-earth dependency factor into your resilience vs. direct-drive rivals?
11. Cyclicality: what is the trough margin you'd underwrite in a European auction air-pocket, and how variable is the cost base?
12. Backlog quality: of the €17bn order book, how much is firm/financed vs. conditional, and what is realistic cancellation/slippage risk?
13. Dilution: is the share-count growth behind you, or should holders expect further equity issuance?
14. Offshore: any scenario in which Nordex re-enters offshore, or is onshore-only permanent?
15. Talent/execution: what are the binding constraints on scaling installations (skilled labour, logistics, grid connection) as you ramp toward €9–10bn revenue?

---